XOVR Promised Pre IPO SpaceX Upside, But It Is Down 2% YTD While the S&P 500 Is Up 9%

ERShares Private-Public Crossover ETF (XOVR) holds about $281 million in SpaceX, or roughly 23% of assets, but has lagged the S&P 500 by more than 7 percentage points this year while charging a 1.81% expense ratio. The article argues the fund’s Level 3 private-mark valuation framework and concentrated exposure have hurt returns versus plain-vanilla growth ETFs like QQQ. A SpaceX IPO, now expected by mid-June with a target valuation near $1.5 trillion, could reprice XOVR sharply and has increased investor interest ahead of the listing.

Analysis

The market is implicitly treating XOVR as a proxy for pre-IPO optionality, but the more important dynamic is that its structure turns timing into a drag. When the underlying private mark is stale and the public sleeve rallies, the ETF behaves like a levered underperformer to the very theme it is supposed to own; that creates a persistent relative-value penalty whenever growth leadership is broad rather than idiosyncratic. In other words, the fund is not just paying fees for access — it is paying fees for a valuation lag that can easily overwhelm the one asset investors actually want.

The real beneficiaries are not necessarily XOVR holders, but the eventual public-market ecosystem around SpaceX. Once the stock lists, capital that wanted exposure without private-market friction will rotate from the ETF into the common equity, while the ETF’s private-market novelty premium collapses. That likely leaves XOVR with a less differentiated portfolio, a still-high fee load, and a public-space exposure that overlaps with existing growth/AI baskets, making it vulnerable to redemption pressure if post-IPO performance is merely ordinary rather than explosive.

On the public holdings, the setup is more nuanced: strong names like NVDA and META can keep masking the structure’s inefficiency for a while, but they also make the fund’s underperformance more visible because investors can compare it directly to liquid benchmarks. RKLB is the cleanest second-order tell — if speculative space-beta is already being bid independently, then XOVR’s incremental value proposition narrows further. The biggest risk to the bearish relative thesis is a sharp, disorderly SpaceX IPO revaluation that forces a step-up in NAV; that is a days-to-weeks catalyst, not a multi-quarter edge.

Consensus is missing that the main trade is likely not long XOVR into the IPO, but long the event and short the wrapper. If the IPO is successful, XOVR may get a one-time NAV pop, but afterward it becomes a high-cost fund holding a now-accessible public mega-cap-like asset. If the IPO disappoints, the private mark can gap down and the ETF has no structural cushion; either way, the asymmetry favors avoiding the wrapper rather than paying for it.

Key Decisions for Investors

• Short XOVR vs long QQQ as a 1-3 month relative-value pair: express the view that liquid growth leadership should outperform a high-fee, stale-mark vehicle unless SpaceX reprices sharply higher.
• Buy a small event-driven call spread on XOVR into the expected IPO window: limited premium outlay, asymmetric upside if the listing forces a rapid mark-up, but size it as a tactical trade rather than a core hold.
• After the IPO prints, rotate from XOVR into direct SpaceX exposure or a liquid growth basket within 1-2 weeks if the stock is tradable; the wrapper premium should decay quickly once the scarcity narrative disappears.
• Fade strength in XOVR on any broad market rally in NVDA/META: use 1-2 week tactical shorts because the fund’s lag versus daily-marked peers can reassert immediately when public names outperform.
• For investors wanting space beta, prefer RKLB over XOVR on a relative basis if the goal is pure public-market upside; XOVR embeds too much valuation lag and fee drag for the same thematic exposure.